SciTransfer
Organization

AKTIOS YPIRESIES YGEIAS KAI PERITHALPSIS ILIKIOMENON KAI CHRONOS PASCHONTON ANONYMI ETAIREIA

Greek residential care operator providing real-world test environments for assistive robots and smart monitoring in elderly and chronic illness care.

Healthcare service provider (care facility)healthELSMENo active H2020 projectsThin data (2/5)
H2020 projects
2
As coordinator
0
Total EC funding
€211K
Unique partners
38
What they do

Their core work

AKTIOS AE is a Greek private company providing health and residential care services for elderly and chronically ill patients — the name translates directly to "AKTIOS Health and Care Services for the Elderly and Chronically Ill." Their core business is operating care facilities where staff deliver day-to-day personal care, health monitoring, and assisted living support. In the H2020 context, they served as a real-world clinical testbed: research consortia brought robots and smart monitoring technologies into their facilities to trial them with actual residents under operational conditions. This makes AKTIOS AE a rare bridge between assistive technology research and front-line eldercare practice.

Core expertise

What they specialise in

Residential elderly care operationsprimary
2 projects

Both ENRICHME and ACROSSING centred on assisted living environments, with AKTIOS AE contributing as an active care facility deploying and evaluating these technologies on-site.

Ambient Assisted Living (AAL) deploymentprimary
2 projects

AAL is the top keyword across their portfolio, with both projects (ENRICHME, ACROSSING) focused on technology-enabled independent and residential care.

Human-robot interaction in care settingssecondary
1 project

ENRICHME (2015–2018) explicitly targeted long-term human-robot interaction with elderly residents, positioning AKTIOS as a live test environment for social care robotics.

Non-invasive physiological monitoringsecondary
1 project

Non-invasive physiological monitoring appears as a keyword in ENRICHME, reflecting their role in validating unobtrusive health-tracking systems within a real care facility.

Gerontology and chronic illness caresecondary
1 project

Gerontology is explicitly listed in ENRICHME keywords, grounding their participation in clinical knowledge of ageing and age-related conditions rather than purely technological expertise.

Evolution & trajectory

How they've shifted over time

Early focus
Elderly care robotics and AAL
Recent focus
Smart assisted living platforms

Both H2020 projects started within a year of each other (2015 and 2016), so there is very limited temporal spread to map a meaningful evolution. The early period is richly described — residential care robotics, AAL, non-invasive monitoring, gerontology — while the more recent project (ACROSSING) carries no recorded keywords, making a trajectory comparison unreliable. What can be said is that their move from ENRICHME (robot companion for elderly monitoring) to ACROSSING (broader smart assisted living platform) suggests a widening scope: from a single robot intervention to a multi-technology platform approach, still within the same eldercare domain.

Their trajectory points toward broader smart-environment solutions for eldercare, but with only two projects and no activity recorded beyond 2019, it is unclear whether they remain active in EU research or returned to purely operational care work.

Collaboration profile

How they like to work

Role: specialist_contributorReach: European14 countries collaborated

AKTIOS AE has never coordinated a project — they join consortia as a participant or third-party contributor, consistent with a care-facility organisation that offers real-world access rather than research leadership. Despite only two projects, they accumulated 38 unique partners across 14 countries, indicating they joined large, well-networked consortia rather than small focused teams. This pattern suggests they are sought out as a deployment site, not as a scientific or technical driver.

Through just two projects, AKTIOS AE connected with 38 distinct consortium partners spanning 14 countries — a notably broad reach for a small care provider. This reflects the large, pan-European consortia typical of RIA and MSCA-ETN projects in the AAL space, where real care facilities are essential but rare partners.

Why partner with them

What sets them apart

What distinguishes AKTIOS AE is not technology or research capacity, but operational access: they provide a functioning residential care environment where researchers can deploy and validate assistive systems with real elderly patients under real care conditions. This is a scarce commodity in AAL research — most technology partners lack clinical settings and patient populations. For any consortium building AAL tools, robotic companions, or remote health monitoring systems, a partner like AKTIOS AE transforms a laboratory prototype into something that can be tested at TRL 6–7 in authentic daily care routines.

Notable projects

Highlights from their portfolio

  • ENRICHME
    The organisation's only funded project (€210,625), focused on deploying a companion robot for long-term interaction and health monitoring with elderly residents — the most concrete evidence of their role as a live care-facility testbed.
  • ACROSSING
    Participation as a third party in a broader smart assisted living platform project shows their reach beyond a single technology, though their specific contribution is not detailed in available data.
Cross-sector capabilities
Assistive and social robotics validation in live environmentsDigital health monitoring and remote patient observationHuman-computer interaction research with vulnerable and elderly populationsEthics and real-world compliance testing for care technologies
Analysis note: Only 2 projects, both starting in 2015–2016, with no H2020 activity recorded after 2019. The second project (ACROSSING) carries no keywords, making the early-vs-recent trend analysis unreliable. The organisation's core value is clearly as a real-world care-facility partner, but depth of their scientific or technical contribution beyond site access cannot be confirmed from available data. Confidence is low: the profile is directionally correct but would benefit from direct verification of their current operational status and any post-H2020 research involvement.